Sign in Subscribe
Coronaviruses

COVID-19 Restrictions Linked to Delayed Immunity in Young Children

Strategic Insights

— 1 min read

A new study from Imperial College London has revealed that the COVID-19 pandemic may have led to a significant delay in the acquisition of immunity to common respiratory pathogens, including Streptococcus pyogenes, in young children. The research, published in JAMA Network Open, found that the introduction of nonpharmaceutical interventions (NPIs) during the pandemic was associated with a decrease in the detection of several respiratory pathogens, including S pyogenes, respiratory syncytial virus (RSV), and influenza viruses. However, the study also found that the antibodies to these pathogens were significantly lower in children aged 3 to 4 years who were recruited after the introduction of NPIs compared to those recruited before.

Key Takeaways:

  • The study found a significant decrease in the detection of S pyogenes, RSV, common cold coronaviruses, and influenza viruses between March 2020 to July 2021, corresponding to the maximal period of NPIs.
  • Antibodies to S pyogenes were measured in 252 children recruited before NPIs and 200 thereafter, with significantly lower levels of antibodies in the latter group.
  • Total IgG to S pyogenes and RSV was significantly lower in children aged 3 to 4 years recruited after NPI introduction compared with those recruited before.
  • The research concluded that the data suggest a putative biological basis for the 2022 to 2023 upsurge in severe S pyogenes infections in this age group, equivalent to approximately a 1-year delay in acquisition of immunity.

Statistics:

  • 1942 children aged 0 to 4 years were tested for respiratory pathogens, with 1449 recruited before the introduction of NPIs and 493 recruited after.
  • The median age of the children recruited before the introduction of NPIs was 19.7 months, while the median age of the children recruited after was 20.7 months.
  • The number of male children was 55.1% in the pre-NPI group and 54.7% in the post-NPI group.

Sources:

  • Immunity to Streptococcus pyogenes and Common Respiratory Viruses at Age 0 to 4 Years After COVID-19 Restrictions. JAMA Network Open, 2025;8(10).
  • Report provided by NewsRx, Pediatrics Week.

Read more